16 RECYCLING SEMAGLUTIDE AS A NEW DRUG Semaglutide is marketed as three products under distinct brand names: Ozempic (injection for diabetes, approved in 2017), Rybelsus (oral tablet for diabetes, approved in 2019) and Wegovy (injection for weight loss, approved in 2021)
Each batch is produced according to the compounding pharmacy's own protocols, tested by their own quality control processes (or third-party labs they select), and released based on their own standards
Wegovy is approved by Health Canada for chronic weight management in adults with a specific BMI or weight-related health conditions
It's also the most scrutinized anemia code in claim submissions, and defaulting to it when an iron deficiency anemia icd 10 option or another specific code fits the documentation creates preventable denials
The outcome is enhanced joint function and a reduction in pain , offering a promising avenue for those seeking respite from the limitations imposed by joint-related ailments